These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39149973)

  • 1. Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles.
    Boussios S; Ovsepian SV
    Technol Cancer Res Treat; 2024; 23():15330338241275403. PubMed ID: 39149973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal cell carcinoma].
    Fornara P; Hoda MR
    Urologe A; 2011 Sep; 50 Suppl 1():219-22. PubMed ID: 21837488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the research of exosomes in renal cell carcinoma: from mechanisms to applications.
    Rui R; Zhou L; He S
    Front Immunol; 2023; 14():1271669. PubMed ID: 37942325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal cell carcinoma: what is new in 2010?].
    Tsaur I; Haferkamp A
    Urologe A; 2011 Sep; 50 Suppl 1():216-8. PubMed ID: 21837489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma and proteomics.
    Sandim V; Pereira DA; Ornellas AA; Alves G
    Urol Int; 2010; 84(4):373-7. PubMed ID: 20224258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma.
    Zhang Y; Luo CL; He BC; Zhang JM; Cheng G; Wu XH
    Int J Oncol; 2010 Jan; 36(1):133-40. PubMed ID: 19956842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of research on exosomes in general, and for the diagnosis and treatment of kidney cancer in particular.
    Mao W; Wang K; Wu Z; Xu B; Chen M
    J Exp Clin Cancer Res; 2021 Sep; 40(1):305. PubMed ID: 34583759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant.
    Tsuruda M; Yoshino H; Okamura S; Kuroshima K; Osako Y; Sakaguchi T; Sugita S; Tatarano S; Nakagawa M; Enokida H
    PLoS One; 2020; 15(5):e0232545. PubMed ID: 32379831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
    Gao X; Jiang P; Zhang Q; Liu Q; Jiang S; Liu L; Guo M; Cheng Q; Zheng J; Yao H
    J Exp Clin Cancer Res; 2019 Aug; 38(1):362. PubMed ID: 31426831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.
    Liu Y; Fu W; Cao X; Li S; Xiong T; Zhang X; Wu X; Cheng L; Wei Y; Gao B
    Comput Math Methods Med; 2021; 2021():5517747. PubMed ID: 34122615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
    Zeng Q; Zhang W; Li X; Lai J; Li Z
    Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.
    Yu X; Du Z; Zhu P; Liao B
    Pharmacol Rep; 2024 Apr; 76(2):273-286. PubMed ID: 38388810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential protein profiling of renal cell carcinoma urinary exosomes.
    Raimondo F; Morosi L; Corbetta S; Chinello C; Brambilla P; Della Mina P; Villa A; Albo G; Battaglia C; Bosari S; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1220-33. PubMed ID: 23511837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
    Cooley LS; Rudewicz J; Souleyreau W; Emanuelli A; Alvarez-Arenas A; Clarke K; Falciani F; Dufies M; Lambrechts D; Modave E; Chalopin-Fillot D; Pineau R; Ambrosetti D; Bernhard JC; Ravaud A; Négrier S; Ferrero JM; Pagès G; Benzekry S; Nikolski M; Bikfalvi A
    Mol Cancer; 2021 Oct; 20(1):136. PubMed ID: 34670568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights in Kidney Cancer.
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):423-424. PubMed ID: 32903254
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights.
    Chen YY; Hu HH; Wang YN; Liu JR; Liu HJ; Liu JL; Zhao YY
    Arch Biochem Biophys; 2020 Nov; 695():108623. PubMed ID: 33039388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer.
    Cheng Y; Xu T; Li S; Ruan H
    Aging (Albany NY); 2019 Dec; 11(24):12165-12176. PubMed ID: 31844035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma.
    Grange C; Brossa A; Bussolati B
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.